NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Cash from Financing Activities of -$3.0 million for Q4 2025, down 551.19% year-over-year from $670000.0 in Q4 2024, and down 104.98% quarter-over-quarter from $60.7 million in Q3 2025.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Cash from Financing Activities (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Cash from Financing Activities for 4 consecutive years, with -$3.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 551.19% year-over-year to -$3.0 million; the TTM figure through Dec 2025 stood at $58.4 million (down 85.71% YoY), while the FY2025 annual figure was $57.7 million, up 17131.34% from the prior year.
- Cash from Financing Activities eased to -$3.0 million in Q4 2025 per NBP's latest filing, from $60.7 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $60.7 million in Q3 2025 and bottomed at -$3.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.42 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -6.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -273.15 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 27.18 Mn |
| 10 | NovaBridge Biosciences | 197.68 Mn | 197.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | 60.75 Mn |
| Dec 31, 2020 | 127.47 Mn |
| Sep 30, 2020 | 280.56 Mn |
| Dec 31, 2019 | 16.07 Mn |